Literature DB >> 15312030

The handicap of abnormal colour vision.

Barry L Cole1.   

Abstract

All people with abnormal colour vision, except for a few mildly affected deuteranomals, report that they experience problems with colour in everyday life and at work. Contemporary society presents them with increasing problems because colour is now so widely used in printed materials and in computer displays. Equal opportunity law gives them protection against unfair discrimination in employment, so a decision to exclude a person from employment on the grounds of abnormal colour vision must now be well supported by good evidence and sound argument. This paper reviews the investigations that have contributed to understanding the nature and consequences of the problems they have. All those with abnormal colour vision are at a disadvantage with comparative colour tasks that involve precise matching of colours or discrimination of fine colour differences either because of their loss of colour discrimination or anomalous perception of metamers. The majority have problems when colour is used to code information, in man-made colour codes and in naturally occurring colour codes that signal ripeness of fruit, freshness of meat or illness. They can be denied the benefit of colour to mark out objects and organise complex visual displays. They may be unreliable when a colour name is used as an identifier. They are slower and less successful in search when colour is an attribute of the target object or is used to organise the visual display. Because those with the more severe forms of abnormal colour vision perceive a very limited gamut of colours, they are at a disadvantage in the pursuit and appreciation of those forms of art that use colour.

Entities:  

Mesh:

Year:  2004        PMID: 15312030     DOI: 10.1111/j.1444-0938.2004.tb05056.x

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  13 in total

1.  Colour vision problems.

Authors:  Euan Lawson
Journal:  Br J Gen Pract       Date:  2010-11       Impact factor: 5.386

2.  Impact of congenital colour vision deficiency: congenital colour vision deficiency does cause problems.

Authors:  Barry L Cole
Journal:  BMJ       Date:  2005-01-08

3.  Blue-yellow dyschromatopsia in toluene-exposed workers.

Authors:  Axel Muttray; Volkmar Wolters; Dirk-Matthias Rose
Journal:  Int Arch Occup Environ Health       Date:  2019-01-25       Impact factor: 3.015

4.  Impact of congenital colour vision defects on occupation.

Authors:  P Cumberland; J S Rahi; C S Peckham
Journal:  Arch Dis Child       Date:  2005-05-24       Impact factor: 3.791

5.  Prevalence Of Colour Vision Deficiency Among Medical Students And Health Personnel.

Authors:  R Balasundaram; Sagili Chandrasekhara Reddy
Journal:  Malays Fam Physician       Date:  2006-08-31

6.  Prevalence of congenital colour vision deficiency among Black school children in Durban, South Africa.

Authors:  Khathutshelo Percy Mashige; Diane Beverly van Staden
Journal:  BMC Res Notes       Date:  2019-06-10

7.  Visual Search in the Real World: Color Vision Deficiency Affects Peripheral Guidance, but Leaves Foveal Verification Largely Unaffected.

Authors:  Günter Kugler; Bernard M 't Hart; Stefan Kohlbecher; Klaus Bartl; Frank Schumann; Wolfgang Einhäuser; Erich Schneider
Journal:  Front Hum Neurosci       Date:  2015-12-22       Impact factor: 3.169

8.  Development and validation of a questionnaire assessing the quality of life impact of Colour Blindness (CBQoL).

Authors:  John A Barry; Susan Mollan; Michael A Burdon; Michelle Jenkins; Alastair K Denniston
Journal:  BMC Ophthalmol       Date:  2017-10-02       Impact factor: 2.209

9.  Impact of congenital color vision defect on color-related tasks among schoolchildren in Durban, South Africa.

Authors:  Khathutshelo Percy Mashige
Journal:  Clin Optom (Auckl)       Date:  2019-08-13

10.  Contact Lenses for Color Blindness.

Authors:  Abdel-Rahman Badawy; Muhammad Umair Hassan; Mohamed Elsherif; Zubair Ahmed; Ali K Yetisen; Haider Butt
Journal:  Adv Healthc Mater       Date:  2018-04-26       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.